BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bellenghi M, Puglisi R, Pontecorvi G, De Feo A, Carè A, Mattia G. Sex and Gender Disparities in Melanoma. Cancers (Basel) 2020;12:E1819. [PMID: 32645881 DOI: 10.3390/cancers12071819] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Fawzy MS, Ibrahiem AT, Bayomy NA, Makhdoom AK, Alanazi KS, Alanazi AM, Mukhlef AM, Toraih EA. MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma. Diagnostics (Basel) 2023;13:1205. [PMID: 36980512 DOI: 10.3390/diagnostics13061205] [Reference Citation Analysis]
2 Diaz MJ, Mark I, Rodriguez D, Gelman B, Tran JT, Kleinberg G, Levin A, Beneke A, Root KT, Tran AXV, Lucke-Wold B. Melanoma Brain Metastases: A Systematic Review of Opportunities for Earlier Detection, Diagnosis, and Treatment. Life (Basel) 2023;13:828. [PMID: 36983983 DOI: 10.3390/life13030828] [Reference Citation Analysis]
3 Unar A, Khan H, Zahid N, Khan MA, Fatima S, Shaikh SA, Rahman MF. Association of the Depth of Invasion With Recurrence Rates of Basal Cell Carcinoma in a Tertiary Health Care Facility: A Retrospective Study Over a Period of Six Years. Cureus 2023. [DOI: 10.7759/cureus.36276] [Reference Citation Analysis]
4 Koczkodaj P, Sulkowska U, Didkowska J, Rutkowski P, Mańczuk M. Melanoma Mortality Trends in 28 European Countries: A Retrospective Analysis for the Years 1960-2020. Cancers (Basel) 2023;15. [PMID: 36900305 DOI: 10.3390/cancers15051514] [Reference Citation Analysis]
5 Liszkay G, Benedek A, Polgár C, Oláh J, Holló P, Emri G, Csejtei A, Kenessey I, Polányi Z, Knollmajer K, Várnai M, Vokó Z, Nagy B, Rokszin G, Fábián I, Barcza Z, Gyulai R, Kiss Z. Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019. J Eur Acad Dermatol Venereol 2023. [PMID: 36785988 DOI: 10.1111/jdv.18960] [Reference Citation Analysis]
6 Lallas K, Anagnostis P, Theocharis P, Boureka E, Kyrgidis A, Klonos E, Papazisis G, Apalla Z, Lallas A, Vakirlis E. The effect of menopausal hormone therapy on the risk of melanoma and keratinocyte skin cancer: A systematic review and meta-analysis of observational studies. Maturitas 2023;168:20-8. [PMID: 36372010 DOI: 10.1016/j.maturitas.2022.10.010] [Reference Citation Analysis]
7 Jitian Mihulecea CR, Rotaru M. Review: The Key Factors to Melanomagenesis. Life (Basel) 2023;13. [PMID: 36676131 DOI: 10.3390/life13010181] [Reference Citation Analysis]
8 Liu M, Li W, Ma X, Che Y, Wei B, Chen M, Zhong L, Zhao S, Chen A, Pang Y, Zeng J, Guo J. Gradient differences of immunotherapy efficacy in metastatic melanoma related to sunlight exposure pattern: A population-based study. Front Oncol 2022;12:1086664. [PMID: 36686834 DOI: 10.3389/fonc.2022.1086664] [Reference Citation Analysis]
9 Seyedmirzaei H, Rezaei N. Epigenetics and Circular RNAs in Cancer. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_33-1] [Reference Citation Analysis]
10 Jeremić J, Suđecki B, Radenović K, Mihaljević J, Radosavljević I, Jovanović M, Milić N, Pavlović V, Brašanac D, Jović M. Impact of the COVID-19 Pandemic on Melanoma Diagnosis: Increased Breslow Thickness in Primary Melanomas-A Single Center Experience. Int J Environ Res Public Health 2022;19. [PMID: 36554683 DOI: 10.3390/ijerph192416806] [Reference Citation Analysis]
11 Peppicelli S, Ruzzolini J, Lulli M, Biagioni A, Bianchini F, Caldarella A, Nediani C, Andreucci E, Calorini L. Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells. Int J Mol Sci 2022;23. [PMID: 36499700 DOI: 10.3390/ijms232315374] [Reference Citation Analysis]
12 Kudura K, Basler L, Nussbaumer L, Foerster R. Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition. Cancers (Basel) 2022;14. [PMID: 36291928 DOI: 10.3390/cancers14205145] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sabag N, Yakobson A, Retchkiman M, Silberstein E. Novel Biomarkers and Therapeutic Targets for Melanoma. Int J Mol Sci 2022;23:11656. [PMID: 36232957 DOI: 10.3390/ijms231911656] [Reference Citation Analysis]
14 Frantsiyants EM, Bandovkina VA, Kaplieva IV, Surikova EI, Shlyk SV, Neskubina IV, Pogorelova YA, Trepitaki LK, Kotieva IM, Shumarin KA. LEVELS OF CERTAIN HORMONES AND RECEPTORS IN TUMOR AND PERITUMORAL AREA IN BALB/C NUDE FEMALE MICE WITH MULTIPLE PRIMARY MALIGNANT PROCESS DEVELOPING ON THE BACKGROUND OF PRIMARY IMMUNODEFICIENCY. Ulyanovsk Medico-biological Journal 2022. [DOI: 10.34014/2227-1848-2022-3-129-141] [Reference Citation Analysis]
15 Lopes J, Rodrigues CMP, Gaspar MM, Reis CP. Melanoma Management: From Epidemiology to Treatment and Latest Advances. Cancers 2022;14:4652. [DOI: 10.3390/cancers14194652] [Reference Citation Analysis]
16 Díez-Solinska A, Lebeña A, Garmendia L, Labaka A, Azkona G, Perez-Tejada J, Vegas O. Chronic social instability stress down-regulates IL-10 and up-regulates CX3CR1 in tumor-bearing and non-tumor-bearing female mice. Behav Brain Res 2022;435:114063. [PMID: 35988637 DOI: 10.1016/j.bbr.2022.114063] [Reference Citation Analysis]
17 Stoyanova E, Mihaylova N, Ralchev N, Ganova P, Bradyanova S, Manoylov I, Raynova Y, Idakieva K, Tchorbanov A. Antitumor Properties of Epitope-Specific Engineered Vaccine in Murine Model of Melanoma. Mar Drugs 2022;20:392. [PMID: 35736195 DOI: 10.3390/md20060392] [Reference Citation Analysis]
18 Kostner L, Cerminara SE, Pamplona GSP, Maul JT, Dummer R, Ramelyte E, Mangana J, Wagner NB, Cozzio A, Kreiter S, Kogler A, Streit M, Wysocki A, Zippelius A, Läubli H, Navarini AA, Maul LV. Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers (Basel) 2022;14. [PMID: 35625961 DOI: 10.3390/cancers14102360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Liszkay G, Benedek A, Polgár C, Oláh J, Holló P, Emri G, Csejtei A, Kenessey I, Polányi Z, Knollmajer K, Várnai M, Vokó Z, Nagy B, Rokszin G, Fábián I, Barcza Z, Gyulai R, Kiss Z. SIGNIFICANT IMPROVEMENT IN MELANOMA SURVIVAL OVER THE LAST DECADE: A HUNGARIAN NATIONWIDE STUDY BETWEEN 2011–2019.. [DOI: 10.1101/2022.04.06.22273390] [Reference Citation Analysis]
20 Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, Cust AE, de Vries E, Whiteman DC, Bray F. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol 2022. [PMID: 35353115 DOI: 10.1001/jamadermatol.2022.0160] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
21 Fisher JL, Jones EF, Flanary VL, Williams AS, Ramsey EJ, Lasseigne BN. Considerations and challenges for sex-aware drug repurposing. Biol Sex Differ 2022;13:13. [PMID: 35337371 DOI: 10.1186/s13293-022-00420-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chrysanthou E, Sehovic E, Ostano P, Chiorino G. Comprehensive Gene Expression Analysis to Identify Differences and Similarities between Sex- and Stage-Stratified Melanoma Samples. Cells 2022;11:1099. [DOI: 10.3390/cells11071099] [Reference Citation Analysis]
23 Hegedüs L, Livingstone E, Bánkfalvi Á, Viehof J, Enyedi Á, Bilecz Á, Győrffy B, Baranyi M, Tőkés A, Gil J, Marko-varga G, Griewank KG, Zimmer L, Váraljai R, Sucker A, Zaremba A, Schadendorf D, Aigner C, Hegedüs B. The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition. IJMS 2022;23:3324. [DOI: 10.3390/ijms23063324] [Reference Citation Analysis]
24 Carè A, Del Bufalo D, Facchiano A. Editorial on Special Issue “Advances and Novel Treatment Options in Metastatic Melanoma”. Cancers 2022;14:707. [DOI: 10.3390/cancers14030707] [Reference Citation Analysis]
25 Buja A, Rugge M, Damiani G, Zorzi M, De Toni C, Vecchiato A, Del Fiore P, Spina R, Baldo V, Brazzale AR, Rossi CR, Mocellin S. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs. J Womens Health (Larchmt) 2022. [PMID: 35076310 DOI: 10.1089/jwh.2021.0223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Guddati AK, Picon H. Analysis of Demographics and Outcomes of Surgical Resection in the Central Nervous System of Patients With Metastatic Melanoma. World J Oncol 2021;12:225-31. [PMID: 35059082 DOI: 10.14740/wjon1408] [Reference Citation Analysis]
27 Wu L, Hu X, Dai H, Chen K, Liu B. Identification of an m6A Regulators-Mediated Prognosis Signature For Survival Prediction and Its Relevance to Immune Infiltration in Melanoma. Front Cell Dev Biol 2021;9:718912. [PMID: 34900983 DOI: 10.3389/fcell.2021.718912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Li Z, Fang Y, Chen H, Zhang T, Yin X, Man J, Yang X, Lu M. Spatiotemporal trends of the global burden of melanoma in 204 countries and territories from 1990 to 2019: Results from the 2019 global burden of disease study. Neoplasia 2022;24:12-21. [PMID: 34872041 DOI: 10.1016/j.neo.2021.11.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
29 Hajdú T, Kovács P, Zsigrai E, Takács R, Vágó J, Cho S, Sasi-Szabó L, Becsky D, Keller-Pinter A, Emri G, Rácz K, Reglodi D, Zákány R, Juhász T. Pituitary Adenylate Cyclase Activating Polypeptide Has Inhibitory Effects on Melanoma Cell Proliferation and Migration In Vitro. Front Oncol 2021;11:681603. [PMID: 34616669 DOI: 10.3389/fonc.2021.681603] [Reference Citation Analysis]
30 D'Ecclesiis O, Caini S, Martinoli C, Raimondi S, Gaiaschi C, Tosti G, Queirolo P, Veneri C, Saieva C, Gandini S, Chiocca S. Gender-Dependent Specificities in Cutaneous Melanoma Predisposition, Risk Factors, Somatic Mutations, Prognostic and Predictive Factors: A Systematic Review. Int J Environ Res Public Health 2021;18:7945. [PMID: 34360236 DOI: 10.3390/ijerph18157945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wu Y, Zeng M, Xu R, Zhang B, Wang S, Li B, Kan Y, Cao B, Zheng X, Feng W. Inhibitory activity of acteoside in melanoma via regulation of the ERβ-Ras/Raf1-STAT3 pathway. Arch Biochem Biophys 2021;710:108978. [PMID: 34174222 DOI: 10.1016/j.abb.2021.108978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Zurac S, Nichita L, Mateescu B, Mogodici C, Bastian A, Popp C, Cioplea M, Socoliu C, Constantin C, Neagu M. COVID‑19 vaccination and IgG and IgA antibody dynamics in healthcare workers. Mol Med Rep 2021;24:578. [PMID: 34132379 DOI: 10.3892/mmr.2021.12217] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
33 Rashid S, Tsao H. Recognition, Staging, and Management of Melanoma. Med Clin North Am 2021;105:643-61. [PMID: 34059243 DOI: 10.1016/j.mcna.2021.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Collier V, Musicante M, Patel T, Liu-Smith F. Sex disparity in skin carcinogenesis and potential influence of sex hormones. Skin Health Dis 2021;1:e27. [PMID: 35664979 DOI: 10.1002/ski2.27] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Aggarwal P, Knabel P, Fleischer AB Jr. United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. J Am Acad Dermatol 2021;85:388-95. [PMID: 33852922 DOI: 10.1016/j.jaad.2021.03.109] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
36 Benna C, Rajendran S, Spiro G, Menin C, Dall'Olmo L, Rossi CR, Mocellin S. Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility. J Transl Med 2021;19:57. [PMID: 33549124 DOI: 10.1186/s12967-021-02725-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Cesati M, Scatozza F, D'Arcangelo D, Antonini-Cappellini GC, Rossi S, Tabolacci C, Nudo M, Palese E, Lembo L, Di Lella G, Facchiano F, Facchiano A. Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker. Cancers (Basel) 2020;12:E3680. [PMID: 33302400 DOI: 10.3390/cancers12123680] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
38 Park EJ, Yoon C, Han JS, Lee GH, Kim DW, Park EJ, Lim HJ, Kang MS, Han HY, Seol HJ, Kim KP. Effect of PM10 on pulmonary immune response and fetus development. Toxicol Lett 2021;339:1-11. [PMID: 33301788 DOI: 10.1016/j.toxlet.2020.11.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]